A carregar...
Novel chemical compound SINCRO with dual function in STING‐type I interferon and tumor cell death pathways
Recent years have seen a number of regulatory approvals for immune oncology or immunotherapies based on their ability to enhance antitumor immune responses. Nevertheless, the majority of patients remain refractory to these treatments; hence, new therapies that augment current immunotherapies are req...
Na minha lista:
| Publicado no: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6125434/ https://ncbi.nlm.nih.gov/pubmed/29981256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13726 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|